In addition, ADCY3 expression was upregulated 1.312-fold in AML vs. control, and ADCY5 and ADCY6 expression was upregulated 1.025-fold and 1.105-fold, respectively. The gene discussed is ADCY3; the disease is acute myeloid leukemia.